| 1. | nomaam4565 | |
| 2. | pierceton | |
| 3. | dianamoonblade1 | |
| 4. | SugarDaddy | |
| 5. | nshsn8vjkdpyvqf |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | SugarDaddy 02/21/2018 Announces positive top-line results from Phase 3 study |
| 2. | dianamoonblade1 02/05/2018 Granted orphan drug designation by the FDA for Imbruvica for the treatment of gastric cancer, including gast… |
| 3. | SugarDaddy 10/18/2017 {Image} |
| 4. | dianamoonblade1 03/27/2018 Chicago jury has ordered AbbVie to pay a man $3M who claimed the company misrepresented the risks of its tes… |
| 5. | pierceton 01/26/2018 AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results |
| 6. | pierceton 01/26/2018 ABBV leads the way today as the best performing large cap stock, closing up 13.77%. |
| 7. | dianamoonblade1 02/18/2018 AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks |
| 8. | nomaam4565 03/22/2018 The company's massive Rova-T program has delivered disappointing results. |
| 9. | nomaam4565 07/27/2018 Sees FY18 EPS $7.76-7.86 (Prior $7.66-7.76) |
| 10. | SugarDaddy 07/24/2018 Receives FDA approval of ORILISSA (elagolix) for the management of moderate to severe pain |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
AbbVie Inc.
- ABBV
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.